SYENS Syensqo SA/NV
Syensqo SA/NV, a chemical company, engages in the research, development, and production of advanced materials for industrial and consumer applications worldwide. The company operates through the Materials, Performance & Care, and Other Solutions segments. It offers amine ether, amines, fatty amines, and specialty amines; antioxidants and stabilizers; composites; flavors and fragrances, including vanillin, ethylvanillin, natural vanillin, and cyclopentanone; lithium derivatives; diphenols and hydrocarbon monomers; and phosphorus specialties. The company also provides biobased polymers, inverse emlusion polymers, monomers, specialty monomers, and synthetic polymers; solvents comprising green solvents, flame retardants, and hydrocarbon; specialty chemicals, such as nitric acid; specialty polymers that include aromatic polyamides, aromatics, sulfones, fluorinated fluids, fluoropolymers, high performance polyester, polyethylene, polyolefin, and polyvinylidene chloride; and amphoteric, anionic, blend, cationic, and non-ionic surfactants. It serves the aerospace, automotive, agriculture, batteries, building, consumer goods, electronics, food, green hydrogen, healthcare, industrial, resources, environment, and energy sectors, as well as renewable materials and biotechnology markets. Syensqo SA/NV was founded in 1863 and is headquartered in Brussels, Belgium.…
Industry Peers
ChemicalsKey Statistics
About Syensqo (EBR: SYENS)
›
Syensqo (EBR: SYENS) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Chemicals industry, part of the Basic Materials sector, and reports about 13,000 employees.
The shares were at 76.60 EUR on 19 November 2026, up 15.3% over 52 weeks. Its 52-week range is 41.76 EUR to 83.40 EUR: the price is 8.2% below the high and 83.4% above the low.
Its market capitalisation is 7.81B EUR. It pays a dividend yielding 2.08%, against a median of 4.31% among the dividend payers in that peer group.
Syensqo reports return on equity of -1.0%, an operating margin of 6.5% and revenue up 10.6% year over year.
Its debt exceeds its cash by 1.94B EUR, a debt-to-equity ratio of 0.49. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 15 analysts cover the stock, with an average rating of Buy; their mean price target of 84.37 EUR is 10.1% above the current price. The next earnings report is expected on 25 February 2027.